Grifols (GIKLY) Shareholder's Equity Growth (1y) (2010 - 2025)

Grifols (GIKLY) Shareholder's Equity Growth (1y) (2010 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	-2.40%
Dec 31, 2024	-22.23%
Dec 31, 2023	-0.68%
Dec 31, 2022	3.73%
Dec 31, 2021	1,539.99%
Dec 31, 2020	-107.19%
Dec 31, 2019	41.35%
Dec 31, 2018	25.29%
Jun 30, 2018	20.32%
Dec 31, 2017	6.30%
Jun 30, 2017	2.19%
Dec 31, 2016	11.23%
Sep 30, 2016	10.70%
Dec 31, 2015	8.73%
Sep 30, 2015	5.77%
Mar 31, 2015	16.30%
Dec 31, 2014	16.37%
Sep 30, 2014	29.35%
Jun 30, 2014	21.05%
Mar 31, 2014	17.81%